Skip to content

On this page

Nemluvio

nemolizumab-ilto

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Nemluvio

Proper name

nemolizumab-ilto

Licence type

351(a)

BLA number

761390

Applicant

Galderma Laboratories, L.P.

Center

CDER

Presentations

1

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
30MG	For Injection	Subcutaneous	Autoinjector	Rx	August 12, 2024

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity